$848.90 6.3%
LLY Stock Price vs. AI Score (Last 150 days)
Data gathered: July 18

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Eli Lilly and Company

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

Eli Lilly and Company
Price $848.90
Target Price Sign up
Volume 7,570,000
Market Cap $848B
Year Range $568.29 - $950.46
Dividend Yield 0.55%
PE Ratio 138.88
Revenue per Employee $921,336
Earnings Date August 8 '24
Industry Drug Manufacturers

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '248.77B3.51B5.26B2.24B3.21B2.580
Q4 '239.35B4.17B5.18B2.19B3.6B2.490
Q3 '239.5B3.55B5.95B-57M6.4B0.100
Q2 '238.31B3.62B4.69B1.76B2.32B2.110
Q1 '236.96B3.26B3.7B1.34B1.7B1.620

Insider Transactions View All

LILLY ENDOWMENT INC filed to sell 96,961,114 shares at $942.
July 11 '24
LILLY ENDOWMENT INC filed to sell 96,943,810 shares at $944.9.
July 11 '24
LILLY ENDOWMENT INC filed to sell 96,956,595 shares at $943.1.
July 11 '24
LILLY ENDOWMENT INC filed to sell 96,947,310 shares at $944.1.
July 11 '24
LILLY ENDOWMENT INC filed to sell 97,113,827 shares at $938.
July 11 '24

Congress Trading View All

Politician Filing Date Type Size
Ro Khanna
Jul 8, 24 Sell $1K - $15K
Roger Williams
Jun 12, 24 Buy $1K - $15K
Thomas Tuberville
May 15, 24 Sell $15K - $50K

What is the Market Cap of Eli Lilly and Company?

The Market Cap of Eli Lilly and Company is $848B.

What is Eli Lilly and Company's PE Ratio?

As of today, Eli Lilly and Company's PE (Price to Earnings) ratio is 138.88.

How Many People Work at Eli Lilly and Company?

As of our latest update, Eli Lilly and Company employed approximately 39,000 people worldwide. However, it's important to note that Eli Lilly and Company's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Eli Lilly and Company's revenue per employee?

$921,336. To calculate Eli Lilly and Company's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Eli Lilly and Company report earnings?

Eli Lilly and Company will report its next earnings on August 8 '24.

What is the current stock price of Eli Lilly and Company?

Currently, the price of one share of Eli Lilly and Company stock is $848.90.

How can I analyze the LLY stock price chart for investment decisions?

The LLY stock price chart above provides a comprehensive visual representation of Eli Lilly and Company's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eli Lilly and Company shares. Our platform offers an up-to-date LLY stock price chart, along with technical data analysis and alternative data insights.

Does LLY offer dividends to its shareholders?

Yes, Eli Lilly and Company (LLY) offers dividends to its shareholders, with a dividend yield of 0.55%. This dividend yield represents Eli Lilly and Company's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Eli Lilly and Company in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Eli Lilly and Company?

Some of the similar stocks of Eli Lilly and Company are Johnson & Johnson, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.